ask="2.250"
ask_size="400"
average_daily_volume="576794"
bid="2.200"
bid_size="2000"
book_value="1.373"
change="-0.025"
change_from_200_day_moving_average="-0.762"
change_from_50_day_moving_average="-0.202"
change_from_52_week_high="-6.675"
change_From_52_week_low="0.100"
change_in_percent="-1.111%"
close="2.225"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.310"
ebitda="-61.52M"
eps_estimate_current_year="-1.550"
eps_estimate_next_quarter="-0.380"
eps_estimate_next_year="-1.420"
ex_dividend_date="N/A"
float_shares="36032000"
high="2.300"
high_52_weeks="8.900"
last_trade_date="1/25/2017"
last_trade_price="2.225"
last_trade_size="5043"
last_trade_time="4:00pm"
low="2.200"
low_52_weeks="2.125"
market_capitalization="117.75M"
moving_average_200_day="2.987"
moving_average_50_day="2.427"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="8.600"
open="2.300"
pe_ratio="N/A"
peg_ratio="-0.040"
percent_change_from_200_day_moving_average="-25.502%"
percent_change_from_50_day_moving_average="-8.311%"
percent_change_from_52_week_high="-75.000%"
percent_change_from_52_week_low="+4.706%"
previous_close="2.250"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.639"
price_per_sales="9.893"
revenue="12.04M"
shares_outstanding="52923000"
short_ratio="4.280"
stock_exchange="NGM"
symbol="RGLS"
volume="350536"
weeks_range_52="2.125 - 8.900"
